Achiron A - Search Results

1

Physical activity behavior in people with multiple sclerosis during the COVID-19 pandemic in Israel: Results of an online survey.

Kalron A, Dolev M, Greenberg-Abrahami M, Menascu S, Frid L, Avrech-Shezifi S, Harari G, Magalashvili D, Achiron A. Kalron A, et al. Among authors: achiron a. Mult Scler Relat Disord. 2021 Jan;47:102603. doi: 10.1016/j.msard.2020.102603. Epub 2020 Oct 27. Mult Scler Relat Disord. 2021. PMID: 33246261 Free PMC article.

2

Late-onset multiple sclerosis.

Polliack ML, Barak Y, Achiron A. Polliack ML, et al. Among authors: achiron a. J Am Geriatr Soc. 2001 Feb;49(2):168-71. doi: 10.1046/j.1532-5415.2001.49038.x. J Am Geriatr Soc. 2001. PMID: 11207871

3

Reflexology treatment relieves symptoms of multiple sclerosis: a randomized controlled study.

Siev-Ner I, Gamus D, Lerner-Geva L, Achiron A. Siev-Ner I, et al. Among authors: achiron a. Mult Scler. 2003 Aug;9(4):356-61. doi: 10.1191/1352458503ms925oa. Mult Scler. 2003. PMID: 12926840 Clinical Trial.

4

Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis.

Achiron A, Barak Y, Rotstein Z. Achiron A, et al. Mult Scler. 2003 Oct;9(5):486-91. doi: 10.1191/1352458503ms945oa. Mult Scler. 2003. PMID: 14582775

5

Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis.

Achiron A, Kishner I, Dolev M, Stern Y, Dulitzky M, Schiff E, Achiron R. Achiron A, et al. Among authors: achiron r. J Neurol. 2004 Sep;251(9):1133-7. doi: 10.1007/s00415-004-0495-z. J Neurol. 2004. PMID: 15372259

6

Bone strength in multiple sclerosis: cortical midtibial speed-of-sound assessment.

Achiron A, Edelstein S, Ziev-Ner Y, Givon U, Rotstein Z, Barak Y. Achiron A, et al. Mult Scler. 2004 Oct;10(5):488-93. doi: 10.1191/1352458504ms1076oa. Mult Scler. 2004. PMID: 15471362

7

Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.

Achiron A, Kishner I, Sarova-Pinhas I, Raz H, Faibel M, Stern Y, Lavie M, Gurevich M, Dolev M, Magalashvili D, Barak Y. Achiron A, et al. Arch Neurol. 2004 Oct;61(10):1515-20. doi: 10.1001/archneur.61.10.1515. Arch Neurol. 2004. PMID: 15477504 Clinical Trial.

8

Understanding autoimmune mechanisms in multiple sclerosis using gene expression microarrays: treatment effect and cytokine-related pathways.

Achiron A, Gurevich M, Magalashvili D, Kishner I, Dolev M, Mandel M. Achiron A, et al. Clin Dev Immunol. 2004 Sep-Dec;11(3-4):299-305. doi: 10.1080/17402520400001603. Clin Dev Immunol. 2004. PMID: 15559377 Free PMC article.

9

Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.

Katz U, Kishner I, Magalashvili D, Shoenfeld Y, Achiron A. Katz U, et al. Among authors: achiron a. Autoimmunity. 2006 Sep;39(6):513-7. doi: 10.1080/08916930600825867. Autoimmunity. 2006. PMID: 17060031 Free article.

10

[Physical activity: positive impact on brain plasticity].

Achiron A, Kalron A. Achiron A, et al. Harefuah. 2008 Mar;147(3):252-5, 276. Harefuah. 2008. PMID: 18488869 Review. Hebrew.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters